CD30 Induction and Cytokine Profiles in Hepatitis C Virus Core-Specific Peripheral Blood T Lymphocytes

Journal of Immunology

Volumn 159, Issue 2, 1997, Pages 1012-1018

  Woitas, Rainer P ^a,c   Lechmann, Martin ^a   Jung, Günther ^b   Kaiser, Rolf ^a   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CORE PROTEIN; CYTOKINE; HEPATITIS C ANTIGEN; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; CHRONIC DISEASE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIGEN PRESENTATION; ANTIGENS, CD30; CHRONIC DISEASE; CYTOKINES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; VIRAL CORE PROTEINS;

EID: 0031570824     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Dienstag, J. L. 1983. Non-A, non-B hepatitis: recognition, epidemiology, and clinical features. Gastroenterology 85:439.
2. Alter, H. J., R. H. Purcell, J. W. Shin, C. Melpolder, M. Houghton, Q.-L. Choo, and G. Kuo. 1989. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N. Engl. J. Med. 321:1494.
3. Ferrari, C., A. Valli, L. Galati, A. Penna, P. Scaccaglia, T. Giuberti, C. Schianchi, G. Missale, M. G. Marin, and F. Fiaccadori. 1994. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286.
4. Botarelli, P., M. R. Brunetto, M. A. Minutello, P. Calvo, D. Unutmaz, A. J. Weiner, Q. L. Choo, J. R. Shuster, G. Kuo, F. Bonino, M. Houghton, and S. Abrignani. 1993. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104:580.
5. Del Prete, G., M. De Carli, C. Mastromauro, R. Biagiotti, D. Macchia, P. Falagiani, M. Ricci, and S. Romagnani. 1991. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara runis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88:346.
6. Mosmann, T. R., and S. Subash. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 138:17.
7. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
8. + cells secreting Th1 or Th2 cytokines. Immunity 2:271.
9. Clerici, M., and G. M. Shearer. 1993. A Th1→Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107.
10. Jayamaran, S., A. Heiligenhaus, A. Rodriguez, S. Soukiasian, M. E. Dorf, and C. S. Foster. 1993. Exacerbation of murine herpes simplex virus mediated stromal keratitis by Th2 type T cells. J. Immunol. 151:5777.
11. Romagnani, S. 1995. Biology of human Th1 and Th2 cells, J. Clin. Immunol. 15:121.
12. + T-cell clones producing Th2-type cytokines. Res. Immunol. 145:611.
13. Nagler, A., L. L. Lanier, and J. H. Phillips. 1988. The effects of IL-4 on human natural killer cells: a potent regulator of IL-2 activation and proliferation. J. Immunol. 141:2349.
14. Martinez, O. M., R. S. Gibbons, M. R. Garovoy, and F. R. Aronson. 1990. IL-4 inhibits IL-2 receptor expression and IL-2 dependent proliferation of human T cells. J. Immunol. 144:2211.
15. De Waal Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. deVries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-speciric human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
16. Romagnani, S., G. Del Prete, E. Maggi, M. Chilosi, C. F. Caligans, and G. Pizzolo. 1995. CD30 and type 2 T helper (Th2) responses. J. Leukocyte Biol. 57:726.
17. Pizzolo, G., F. Vinante, L. Morosato, G. Nadali, M. Chilosi, G. Gandini, A. Sinicco, R. Raiteri, G. Semenzato, H. Stein, and G. Perona. 1994. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 8:741.
18. Piccinni, M. P., M. G. Giudizi, R. Biagiotti, L. Beloni, L. Giannarini, S. Sampognaro, P. Parronchi, R. Manetti, F. Annunziato, C. Livi, S. Romagnani, and E. Maggi. 1995. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. 155:128.
19. + T cells producing Th2-type cytokines. FASEB J. 9:81.
20. Del Prete, G., E. Maggi, G. Pizzolo, and S. Romagnani. 1995. CD30. Th2 cytokines and HIV infection: a complex and fascinating link. Immunol. Today 16: 76.
21. Lechmann, M., H. G. Ihlenfeldt, I. Braunschweiger, G. Giers, G. Jung, B. Matz, R. Kaiser, T. Sauerbruch, and U. Spengler. 1996. T and B cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-HCV blood donors without viremia. Hepatology 24:790.
22. Simmonds, P., K. A. Rose, S. Graham, S. W. Chan, F. McOmish, B. C. Dow, E. A. Follett, P. L. Yap, and H. Marsden. 1993. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J. Clin. Microbiol. 31:1493.
23. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
24. Imberti, L., E. Cariani, A. Bettinardi, A. Zonaro, A. Albertini, and D. Primi. 1991. An immunoassay for specific amplilied HCV sequences. J. Virol. Methods 34: 233.
25. Choo, Q.-L., A. J. Weiner, L. R. Overby, and M. Houghton. 1990. Isolation of a cDNA derived from a blood-borne non-A non-B viral hepatitis genome. Science 244:359.
26. King, D. S., C. G. Fields, and G. B. Fields. 1990. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int. J. Pept. Protein Res. 36:255.
27. Jung, T., U. Schauer, C. Heusser, C. Neumann, and C. Rieger. 1993. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 159:197.
28. Tartakoff, A. M. 1983. Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell 32:1026.
29. Pohlmann, R., S. Kruger, A. Hasilik, and K. von Figura. 1984. Effect of monensin on intracellular transport and receptor-mediated endocytosis of lysosomal enzymes. Biochem. J. 217:649.
30. Sander, B., J. Andersson, and U. Andersson. 1991. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 119:65.
31. Shakil, A. O., C. C. Conry, H. J. Alter, P. Hayashi, D. E. Kleiner, V. Tedeschi, K. Krawczynski, H. S. Conjeevaram, R. Sallie. and A. Di Bisceglie. 1995. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann. Intern. Med. 123:330.
32. Zinkernagel, R. M., D. Moskophidis, T. Kundig, S. Oehen, H. P. Pircher, and H. Hengartner. 1993. Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. Immunol. Rev. 131:198.
33. + T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J. Exp. Med. 178:17.
34. + T-cell deficient mice. J. Virol. 68:4700.
35. Weiner, A. J., C. Christopherson, J. E. Hall, F. Bonino, G. Saracco, M. R. Brunetto, K. Crawford, C. D. Marion, K. A. Crawford, S. Venkatakrishna, T. Miyamura, J. McHutchinson, T. Cuypers, and M. Houghton. 1991. Sequence variation in hepatitis C viral isolates. J. Hepatol. 13:S6.
36. Napoli, J., G. A. Bishop, P. H. McGuiness, D. M. Painter, and G. W. McCauchghan. 1996. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-asociated cytokines. Hepatology 4:759.
37. Dumoulin. F. L.. A. Bach, L. Leifeld, M. El Bakri, H. P. Fischer, T. Sauerbruch, and U. Spengler. 1997. Semiquantitative analysis of intrahepatic cytokine mRNA level in chronic hepatitis C. J. Infect. Dis. 175:681.
38. Cacciarelli, T. V., O. M. Martinez, R. G. Gish, J. C. Villanueva, and S. M. Krams. 1996. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre-and posttreatment with interferon alpha. Hepatology 24:6.
39. + T cells from HIV-infected individuals. Immunity 3:251.
40. + T cells isolated from peripheral blood lymphocytes of normal donors. J. Immunol. 157:3229.
41. Alzona, M., H. M. Jack, R. I. Fisher, and T. M. Ellis. 1994. CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 153:21161.
42. + T cells. J. Immunol. 154:9.
43. Hamann, D., C. M. U. Hilkens, J. L. Grogan, S. M. A. Lens, M. L. Kapsenberg, M. Yazdanbakhsh, and R. A. W. van Lier. 1996. CD30 expression does not discriminate between human Th1-and Th2-type T cells. J. Immunol. 156:1387.
44. Amakawa, R., A. Hakem, T. M. Kundig, M. Toshifumi, J. J. L. Simard, E. Timms, A. Wakeham, H.-W. Mittruecker, H. Griesser, H. Takimoto, R. Schmits, A. Shahinian, P. S. Ohashi, J. M. Penninger, and T. W. Mak. 1996. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551.
45. + T cells. J. Immunol. 151:2380.
46. Gruss, H. J., N. Boiani, D. E. Williams, R. J. Armitage, C. A. Smith, and R. G. Goodwin. 1994. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83:2045.
47. Gruss, H. J., and S. K. Dower. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85:3378.
48. McDonald, P. P., M. A. Cassatella, A. Bald, E. Maggi, S. Romagnani, H. J. Gruss, and G. Pizzolo. 1985. CD30 ligation induces nuclear factor-κB activation in human T-cell lines. Eur. J. Immunol. 25:2870.
49. Smith, C. A., H. J. Gruss, T. Davis, D. Anderson, T. Farrah, E. Baker, G. R. Sutherland, C. I. Brannan, N. G. Copeland, N. A. Jenkins, K. H. Grabstein, B. Gliniak, I. B. McAlister, W. Fanslow, M. Alderson, B. Falk, S. Gimpel, S. Gillis, W. S. Din, R. G. Goodwin, and R. J. Armitage. 1993. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349.
50. Durkop, H., U. Latza, M. Hummel, F. Eitelbach, B. Seed, and H. Stein. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421.
51. Wiley, S. R., R. G. Goodwin, and C. A. Smith. 1996. Reverse signaling via CD30 ligand. J. Immunol. 157:3635.
52. Iwata, K., T. Wakita, A. Okumura, K. Yoshioka, M. Takayanagi, J. R. Wands, and S. Kakumu. 1995. Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 22:1057.